Natural product mediated regulation of death receptors and intracellular machinery: Fresh from the pipeline about TRAIL-mediated signaling and natural TRAIL sensitizers

Rapidly developing resistance against different therapeutics is a major stumbling block in the standardization of therapy. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated signaling has emerged as one of the most highly and extensively studied signal transduction cascade that induces apoptosis in cancer cells. Rapidly emerging cutting-edge research has helped us to develop a better understanding of the signaling machinery involved in inducing apoptotic cell death. However, excitingly, cancer cells develop resistance against TRAIL-induced apoptosis through different modes. Loss of cell surface expression of TRAIL receptors and imbalance of stoichiometric ratios of pro- and anti-apoptotic proteins play instrumental roles in rewiring the machinery of cancer cells to develop resistance against TRAIL-based therapeutics. Natural products have shown excellent potential to restore apoptosis in TRAIL-resistant cancer cell lines and in mice xenografted with TRAIL-resistant cancer cells. Significantly refined information has previously been added and continues to enrich the existing pool of knowledge related to the natural-product-mediated upregulation of death receptors, rebalancing of pro- and anti-apoptotic proteins in different cancers. In this mini review, we will set spotlight on the most recently published high-impact research related to underlying mechanisms of TRAIL resistance and how these deregulations can be targeted by natural products to restore TRAIL-mediated apoptosis in different cancers. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.

Dergi Adı International Journal of Molecular Sciences
Cild 20
Dergi Sayısı 8
Sayfalar -
Yayın Tarihi 2019
Eser Adı
[dc.title]
Natural product mediated regulation of death receptors and intracellular machinery: Fresh from the pipeline about TRAIL-mediated signaling and natural TRAIL sensitizers
Yazar
[dc.contributor.author]
Shahwar, D.
Yazar
[dc.contributor.author]
Iqbal, M.J.
Yazar
[dc.contributor.author]
Nisa, M.-U.
Yazar
[dc.contributor.author]
Todorovska, M.
Yazar
[dc.contributor.author]
Attar, Rukset
Yazar
[dc.contributor.author]
Sabitaliyevich, U.Y.
Yazar
[dc.contributor.author]
Xu, B.
Yayıncı
[dc.publisher]
MDPI AG
Yayın Türü
[dc.type]
review
Özet
[dc.description.abstract]
Rapidly developing resistance against different therapeutics is a major stumbling block in the standardization of therapy. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated signaling has emerged as one of the most highly and extensively studied signal transduction cascade that induces apoptosis in cancer cells. Rapidly emerging cutting-edge research has helped us to develop a better understanding of the signaling machinery involved in inducing apoptotic cell death. However, excitingly, cancer cells develop resistance against TRAIL-induced apoptosis through different modes. Loss of cell surface expression of TRAIL receptors and imbalance of stoichiometric ratios of pro- and anti-apoptotic proteins play instrumental roles in rewiring the machinery of cancer cells to develop resistance against TRAIL-based therapeutics. Natural products have shown excellent potential to restore apoptosis in TRAIL-resistant cancer cell lines and in mice xenografted with TRAIL-resistant cancer cells. Significantly refined information has previously been added and continues to enrich the existing pool of knowledge related to the natural-product-mediated upregulation of death receptors, rebalancing of pro- and anti-apoptotic proteins in different cancers. In this mini review, we will set spotlight on the most recently published high-impact research related to underlying mechanisms of TRAIL resistance and how these deregulations can be targeted by natural products to restore TRAIL-mediated apoptosis in different cancers. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.
Kayıt Giriş Tarihi
[dc.date.accessioned]
2020-03-17
Yayın Tarihi
[dc.date.issued]
2019
Açık Erişim Tarihi
[dc.date.available]
2020-03-17
Dil
[dc.language.iso]
eng
Konu Başlıkları
[dc.subject]
Apoptosis
Konu Başlıkları
[dc.subject]
Cancer
Konu Başlıkları
[dc.subject]
Death receptors
Konu Başlıkları
[dc.subject]
Natural products
Konu Başlıkları
[dc.subject]
TRAIL
Haklar
[dc.rights]
info:eu-repo/semantics/openAccess
ISSN
[dc.identifier.issn]
16616596
Dergi Adı
[dc.relation.journal]
International Journal of Molecular Sciences
Dergi Sayısı
[dc.identifier.issue]
8
Cild
[dc.identifier.volume]
20
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.11831/2974
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
43
20.03.2023 tarihinden bu yana
İndirme
1
20.03.2023 tarihinden bu yana
Son Erişim Tarihi
22 Eylül 2023 15:04
Google Kontrol
Tıklayınız
cancer apoptosis different resistance develop against research machinery cancers products proteins related TRAIL-resistant receptors anti-apoptotic Rapidly restore therapeutics signaling knowledge existing enrich continues authors Licensee previously information natural-product-mediated refined Significantly xenografted Switzerland underlying high-impact published
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms